Paychex
PAYX
$118.81
+5.61%
Paychex is a cloud-based human capital management provider delivering payroll processing, compliance, benefits administration, retirement services, and HR outsourcing — including professional employer organization (PEO) offerings — primarily to small and midsize U.S. businesses, with roughly 840,000 clients and payroll for approximately one in eleven American workers. The company is a scaled incumbent in the payroll and HCM oligopoly alongside ADP, distinguished by its high-retention, recurring-revenue model, sticky client relationships, and a distribution network built over five decades since its 1983 listing. The current investor debate centers on the 2025 Paycor acquisition and whether it can successfully push Paychex upmarket into the 100+ employee midmarket segment, where growth is faster but competition from ADP, Workday, and Paylocity is more intense. Sentiment has been pressured by a visible deceleration in organic growth (recent quarterly revenue up 5.9% year over year), rising interest expense tied to acquisition-related leverage, and a soft FY27 outlook that has kept most sell-side analysts on the sidelines with Hold-equivalent ratings.…
PAYX
Paychex
$118.81
Related headlines
Investment Opinion: Should I buy PAYX Today?
Rating: Hold. Paychex is a high-quality, defensive compounder with a 4.3% dividend yield and robust free cash flow, but the current valuation (20.9x trailing PE, 3.2x PEG) already reflects these strengths, and the analyst consensus is Hold with an average target of $113.93, just 2.1% above the current price. The core thesis is that Paycor integration and midmarket expansion could reaccelerate growth, but until that is proven, the risk/reward is balanced.
Supporting evidence: Revenue grew 5.9% year over year in Q1 FY27 to $1.63 billion, with gross margin expanding to 73.6% and operating margin to 38.0%. TTM free cash flow is $2.02 billion, supporting a 4.3% dividend yield, though the payout ratio is high at 90%. The forward PE of 17.5x is below the trailing 20.9x, implying expected earnings growth, and the stock trades at 5.6x sales and 13.4x EV/EBITDA. The average analyst target of $113.93 offers only 2.1% upside, but the high target of $150 suggests 34% potential if Paycor succeeds.
Risks and conditions: The biggest risks are integration missteps with Paycor, a U.S. recession hitting small-business clients, and valuation compression if growth stalls. This Hold would upgrade to Buy if organic revenue growth accelerates above 8% for two consecutive quarters or if the stock pulls back below $95 (near the analyst low target) while fundamentals remain intact. It would downgrade to Sell if organic growth falls below 4%, the dividend payout ratio exceeds 100%, or interest coverage deteriorates further. Relative to its history and peers, PAYX appears fairly valued to slightly overvalued given the growth rate; the 4.3% yield provides a floor, but multiple expansion is unlikely without a growth reacceleration.
Sign up to view all
PAYX 12-Month Price Forecast
Paychex is a high-quality defensive compounder with a 4.3% dividend yield and strong free cash flow, but the growth outlook is muted at ~6% and the valuation is full at 20.9x trailing earnings. The Paycor acquisition adds leverage and integration risk, while the analyst consensus is Hold with limited upside to the average target. The stock's low beta (0.848) and dividend provide downside protection, but relative underperformance versus the S&P 500 (-27.3 percentage points over one year) suggests the market is waiting for proof of a growth reacceleration. I would upgrade to bullish if organic growth exceeds 8% for two consecutive quarters or if the stock pulls back below $95 with fundamentals intact; I would downgrade to bearish if growth falls below 4% or the dividend is cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Paychex's 12-month outlook, with a consensus price target around $113.93 and implied upside of -4.1% versus the current price.
Average Target
$113.93
0 analysts
Implied Upside
-4.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$96 - $150
Analyst target range
Bulls vs Bears: PAYX Investment Factors
The bear case currently has stronger evidence: organic growth has decelerated to 5.9%, leverage has risen sharply (D/E 1.24x, interest expense up ~3x), and the stock has underperformed the S&P 500 by 27 percentage points over the past year. However, the bull case is not without merit — margins are expanding despite Paycor dilution, FCF is robust at $2.0 billion, and the forward PE of 17.5x is reasonable for a defensive, high-yield compounder. The single most important tension is whether Paycor can reaccelerate growth into the midmarket without further margin erosion; if organic growth returns to 8-10%, the stock could re-rate toward the $150 high target, but if growth stalls at 5%, the current 20.9x trailing PE looks vulnerable. Net, the risk/reward is balanced but slightly skewed negative given the Hold consensus and recent relative weakness.
Bullish
- Margin expansion despite Paycor dilution: Gross margin rose to 73.6% in Q1 FY27 from 73.1% a year earlier, and operating margin improved to 38.0% from 35.2%, even as the lower-margin Paycor business was absorbed. Net margin reached 26.4% versus 24.9% in the prior-year quarter, demonstrating pricing power and cost discipline.
- Strong recurring cash generation: TTM free cash flow is $2.02 billion against a $36.8 billion market cap, a 5.5% FCF yield. This funds the 4.3% dividend (payout ratio 90%) and supports deleveraging after the Paycor deal.
- Analyst target implies modest upside: The 14-analyst average target of $113.93 is 2.1% above the $111.63 close, with a high target of $150 (34% upside). Even with a Hold consensus, the skew is not negative, and the forward PE of 17.5x is below the trailing 20.9x, implying earnings growth.
- Low beta defensive profile: Beta of 0.848 versus the S&P 500 means PAYX has historically fallen less in market selloffs. In a late-cycle environment, this defensive characteristic plus a 4.3% dividend yield offers portfolio ballast.
Bearish
- Organic growth decelerating to mid-single digits: Q1 FY27 revenue grew 5.9% year over year to $1.63 billion, a slowdown from the double-digit growth seen in prior cycles. The soft FY27 outlook suggests growth may remain in the 5-6% range, well below the 10%+ growth that historically supported a premium multiple.
- Leverage and interest expense surge: Debt-to-equity is 1.24x and quarterly interest expense jumped to $65.1 million from $22.6 million a year earlier, a nearly 3x increase tied to Paycor financing. This drags on EPS growth and limits balance-sheet flexibility.
- Valuation remains rich for the growth rate: Trailing PE of 20.9x, forward PE of 17.5x, and PEG of 3.21x are elevated for a company growing revenue ~6%. The 4.3% dividend yield is attractive, but the 90% payout ratio leaves little room for dividend growth acceleration.
- Underperformance versus the market: PAYX is down 11.7% over the past year versus the S&P 500's +15.5%, a relative strength gap of -27.3 percentage points. The stock has also lagged over 1-month (-5.6% relative) and 3-month (-5.1% relative) periods, showing persistent negative momentum.
PAYX Technical Analysis
Beta
0.85
0.85x market volatility
Max Drawdown
-35.4%
Largest decline past year
52-Week Range
$85-$128
Price range past year
Annual Return
-6.2%
Cumulative gain past year
| Period | PAYX Return | S&P 500 |
|---|---|---|
| 1m | +3.7% | -1.2% |
| 3m | +4.6% | +3.4% |
| 6m | +32.3% | +7.0% |
| 1y | -6.2% | +14.4% |
| ytd | +9.4% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PAYX Fundamental Analysis
Quarterly Revenue
$1.6B
2026-08
Revenue YoY Growth
+5.9%
YoY Comparison
Gross Margin
73.6%
Latest Quarter
Free Cash Flow
$2.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PAYX Overvalued?
PE
20.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 21x~38x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are centered on the Paycor acquisition. Debt-to-equity stands at 1.24x, and quarterly interest expense has ballooned to $65.1 million from $22.6 million a year ago, consuming a meaningful share of operating income. The payout ratio is 90%, leaving little cushion if earnings disappoint, and the current ratio of 1.26 is adequate but not strong. Revenue concentration in payroll processing for small businesses (~840,000 clients) exposes Paychex to U.S. employment trends; a recession-driven rise in small-business failures would directly hit client retention and revenue. Additionally, the company has no R&D line, suggesting innovation is acquired rather than organic, which raises integration risk.
Market and competitive risks include valuation compression and intensifying competition. At 20.9x trailing earnings and 5.6x sales, PAYX trades at a premium to the broader market for a 5.9% grower; if growth slows further, multiple compression could be severe. The beta of 0.848 offers some downside protection, but the stock has already underperformed the S&P 500 by 27.3 percentage points over the past year, and relative strength remains negative over 1-month and 3-month periods. Competition from ADP, Workday, and Paylocity in the midmarket is fierce, and Paycor's integration may distract management. Regulatory changes to payroll tax or healthcare rules could also disrupt the model.
Worst-case scenario: a U.S. recession triggers small-business bankruptcies, slowing organic growth to low single digits while Paycor integration costs remain high. Interest expense stays elevated, and the dividend payout ratio becomes unsustainable, forcing a cut. In this scenario, the stock could retest its 52-week low of $85.45, implying a 23.5% decline from $111.63. If the analyst low target of $96 is hit, that is a 14.0% drop. A more severe outcome, such as a dividend cut, could push the stock toward the historical max drawdown of -36.8%, though that is less likely given the strong FCF.
FAQ
The most severe risk is a U.S. recession that triggers small-business failures, directly reducing Paychex's client base and revenue; this could push the stock toward its 52-week low of $85.45, a 23.5% decline. Second, Paycor integration risk: the acquisition has increased debt-to-equity to 1.24x and interest expense to $65.1 million per quarter, and if synergies disappoint, earnings could suffer. Third, valuation compression: at 20.9x trailing earnings and a PEG of 3.2x, any slowdown in growth could lead to multiple contraction. Fourth, dividend sustainability: the 90% payout ratio leaves little room for error, and a cut would likely trigger a sharp selloff. Competitive pressure from ADP and Workday in the midmarket is an ongoing threat.
Our 12-month forecast has three scenarios: a base case (55% probability) with a target range of $105-$120, assuming 5-6% revenue growth and stable margins; a bull case (20% probability) targeting $128-$150 if Paycor drives organic growth above 8% and margins expand; and a bear case (25% probability) targeting $85-$96 if a recession hits small businesses and integration costs remain high. The most likely scenario is the base case, with the stock trading around the analyst average target of $113.93. The key assumption is that U.S. employment remains stable and Paycor integration proceeds without major disruptions. The wide bear-bull spread reflects the uncertainty around the Paycor strategy.
PAYX appears fairly valued to slightly overvalued. The trailing PE of 20.9x and forward PE of 17.5x are above the broader market average, and the PEG ratio of 3.2x is high for a company with 5.9% revenue growth. The price-to-sales ratio of 5.6x and EV/EBITDA of 13.4x are also at premiums to historical averages for payroll processors. However, the 4.3% dividend yield and low beta (0.848) justify some premium for defensiveness. The market appears to be pricing in a successful Paycor integration and a return to faster growth; if that does not materialize, the multiple could compress. Compared to its own history, the stock is near the middle of its valuation range, suggesting limited upside from multiple expansion alone.
PAYX is a good buy for income-focused investors seeking a defensive, low-beta holding with a 4.3% dividend yield, but it is less attractive for growth-oriented investors. The stock trades at 20.9x trailing earnings and 17.5x forward earnings, which is reasonable but not cheap for a company growing revenue at 5.9%. The analyst consensus is Hold with an average target of $113.93, implying only 2.1% upside, while the low target of $96 suggests 14% downside. The biggest risk is a recession that hits small businesses, potentially pushing the stock toward its 52-week low of $85.45. For long-term investors comfortable with modest capital appreciation and a solid dividend, PAYX can be a core holding, especially on pullbacks below $100.
PAYX is best suited for long-term investment, with a suggested minimum holding period of 3-5 years. The company is a mature, low-growth dividend payer with a beta of 0.848, making it less volatile than the market but also less likely to deliver quick gains. The 4.3% dividend yield and 90% payout ratio appeal to income investors, while the Paycor integration is a multi-year story that will take time to play out. Short-term traders may find limited catalysts, as the analyst consensus is Hold and the average target implies only 2.1% upside. Earnings visibility is high due to recurring revenue, but growth is slow. For long-term holders, the dividend provides a steady return, and any successful reacceleration could lead to capital appreciation.